AtriCure Announces Near $4 Million False Claims Act Settlement

This morning, medical device company AtriCure, Inc. announced that it would pay $3.8 million plus interest over the next five years to settle allegations that it fraudulently marketed its cardiac ablation devices and that it instructed hospitals to use inncorrect billing codes to falsely inflate Medicare reimbursements.  The company also disclosed that it will enter into a Corporate Integrity Agreement with Health and Human Services.   As of the time of this posting, DoJ had made no public comment on the pending settlement.

To report Medicare fraud, contact Frohsin & Barger.